Ending Aging: Living Beyond 130 Years - Yuri Deigin

Ending Aging: Living Beyond 130 Years - Yuri Deigin

 

In this episode, Yuri discusses new scientific breakthroughs in Aging. Can Stem cells and Yamanaka factors be the key to stopping aging? Can we use Crisper technology to reverse the age of the cell and much more! 

 

"Shinya Yamanaka has shown that an adult cell can be 'reprogrammed' back to embryonic state by OSKM transcription factors. Later research has shown that cells also undergo considerable rejuvenation in the process of reprogramming."

 

Guest

Yuri Deigin, MBA

  http://youthereum.io       Yuri is a serial entrepreneur, an expert in drug development and venture investments in biotechnology and pharmaceuticals.

Yuri brings almost a decade of drug discovery and development experience from his previous role in a biotech startup where he oversaw research and development of original medicines aimed at treating diseases like Alzheimer's and rheumatoid arthritis. Yuri has a track record of not only raising over $20 million for his previous ventures but also initiating and overseeing 4 clinical trials and several pre-clinical studies, including studies in transgenic mice. He also has experience in pharmaceutical product launch, promotion, manufacturing and supply chain management.

Since 2013 Yuri also serves as a vice-president of the non-profit Foundation "Science for Life Extension" whose goal is the popularization of the fight against age-related diseases. To further this cause, Yuri frequently blogs, speaks, writes op-ed pieces, and participates in various TV and radio shows.

Yuri holds a B.Sc. from the University of Toronto and an M.B.A. from Columbia Business School.

Ending Aging: Living Beyond 130 Years - Yuri Deigin

 

In this episode, Yuri discusses new scientific breakthroughs in Aging. Can Stem cells and Yamanaka factors be the key to stopping aging? Can we use Crisper technology to reverse the age of the cell and much more! 

 

"Shinya Yamanaka has shown that an adult cell can be 'reprogrammed' back to embryonic state by OSKM transcription factors. Later research has shown that cells also undergo considerable rejuvenation in the process of reprogramming."

 

Guest

Yuri Deigin, MBA

  http://youthereum.io       Yuri is a serial entrepreneur, an expert in drug development and venture investments in biotechnology and pharmaceuticals. Yuri brings almost a decade of drug discovery and development experience from his previous role in a biotech startup where he oversaw research and development of original medicines aimed at treating diseases like Alzheimer's and rheumatoid arthritis. Yuri has a track record of not only raising over $20 million for his previous ventures but also initiating and overseeing 4 clinical trials and several pre-clinical studies, including studies in transgenic mice. He also has experience in pharmaceutical product launch, promotion, manufacturing and supply chain management. Since 2013 Yuri also serves as a vice-president of the non-profit Foundation "Science for Life Extension" whose goal is the popularization of the fight against age-related diseases. To further this cause, Yuri frequently blogs, speaks, writes op-ed pieces, and participates in various TV and radio shows. Yuri holds a B.Sc. from the University of Toronto and an M.B.A. from Columbia Business School.